General MedicationsINJECTIONGeneric
TERRAMYCIN
LIDOCAINE HYDROCHLORIDE; OXYTETRACYCLINE
Standard Dose
2%;50MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview TERRAMYCIN is listed in Drugs@FDA under application 060567 (ANDA).
Marketing status: Discontinued Active ingredient LIDOCAINE HYDROCHLORIDE; OXYTETRACYCLINE Form and strength INJECTABLE;INJECTION - 2%;50MG/ML Sponsor PFIZER Submission history Latest submission status date: 2004-04-07 00:00:00.
Structured Monograph
Clinical summary
Approval overview TERRAMYCIN is listed in Drugs@FDA under application 060567 (ANDA). Marketing status: Discontinued Active ingredient LIDOCAINE HYDROCHLORIDE; OXYTETRACYCLINE Form and strength INJECTABLE;INJECTION - 2%;50MG/ML Sponsor PFIZER Submission history Latest submission status date: 2004-04-07 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.